Dr. Sheila Kaur Manhas, MD

Dr. Manhas practices at Cordial Healthcare Providers in Glendale, California.

Dr. Manhas' NPI, 1174584965, was assigned on March 31, 2006. Dr. Manhas graduated from University of Alberta in 1997. Dr. Manhas holds California license A88659.

Dr. Manhas' primary practice is Cordial Healthcare Providers, at 121 W Lexington Dr, Glendale, CA 91203 in Los Angeles County. The practice phone is (747) 238-2544.

Dr. Manhas' primary practice is Cordial Healthcare Providers in Glendale, California. The medical group on file is Riverside Optimal Healthcare. Dmand AI also links Dr. Manhas to 6 more group practices and clinics, 5 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manhas practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Manhas' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Manhas is board certified in sleep medicine by the American Board of Family Medicine. Dmand AI has Dr. Manhas' licenses on file in 7 states: California, Washington, Hawaii, Virginia, Alaska, Montana and New Mexico.

Dmand AI lists epilepsy, head injury, migraine and chronic headache, multiple sclerosis, muscle pain, fibromyalgia, and limb pain and non-alzheimer's dementia (chronic) among the conditions Dr. Manhas treats.

CMS data shows 353,433 Medicare services from Dr. Manhas across 26 procedure codes in 2024, for 2,350 Medicare patients. Medicare paid $2,467,634 for them. Every service was in an office.

CMS counts 2,350 Medicare patients who saw Dr. Manhas in 2024. The largest group is 65 to 74, with 1,198 patients. 75% of them have arthritis, and 75% have diabetes. 98% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manhas' median patient age at 71, with 54% women.

In 2024, Dr. Manhas wrote 431 Medicare Part D claims for 104 patients. 82% of them were for generic drugs. CMS names the drug for 223 of them, across 14 drugs with 11 or more claims each, at $41,802 in total drug cost. In 2023, CMS named 288 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Manhas for performance year 2024, reported individually. Dr. Manhas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Manhas as offering telehealth. CMS counts 759 procedures of removal of nail tissue by Dr. Manhas, more than 89% of the clinicians it reports for that procedure.

CMS Open Payments shows 33 general payments to Dr. Manhas from 15 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 64% of the total. Cadwell Industries, INC paid the most, $590.

Dr. Manhas graduated from University of Alberta in 1997.

Dr. Manhas is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.